A combination of Zenbexus, Darzalex and dexamethasone nearly doubled the rate of deep, MRD-negative responses in relapsed multiple myeloma.
|Articles|September 25, 2014
- Fall 2014
- Volume 13
- Issue 3
Thyroid Cancer Survivors' Conference
Author(s)Jon Garinn
The 17th international Thyroid Cancer Survivors' Conference will be held Oct. 17 to 19, 2014 in Denver.
Advertisement
The 17th international Thyroid Cancer Survivors’ Conference will be held Oct. 17 to 19, 2014 in Denver. Sponsored by the nonprofit Thyroid Cancer Survivors Association, the event will feature more than 35 speakers who will discuss the latest advances in treating thyroid cancer, issues related to long-term survivorship, coping skills for well-being and more. A separate dinner and auction supporting thyroid cancer research will be held on Oct. 18. Conference registration is $50. For details, visit
Articles in this issue
about 12 years ago
Low-Risk Cancers: Can We Ignore Them?about 12 years ago
Meeting Dr. Brodieabout 12 years ago
Managing Arthralgiaabout 12 years ago
Pipelineabout 12 years ago
Skin Cancer's Risk is Cumulativeabout 12 years ago
Living with Lymphedemaabout 12 years ago
The DCIS Dilemmaabout 12 years ago
Personalizing Cancer Care with Precision Medicineabout 12 years ago
Preparing for a Cancer-Related Emergencyabout 12 years ago
Are You an Overbearing Caregiver?Advertisement
Related to this article
She was diagnosed with stage 4 primary mediastinal B-cell lymphoma (PMBCL), a type of non-Hodgkin lymphoma that starts in the center of the chest, at 29.
Jyoti Malhotra, MD, MPH on first-in-human clinical trials, lung cancer precision medicine in 2026, the disparities tension in drug development, and her move to Yale Cancer Center.
Dr. Maureen McEvoy explains breast cancer surgery options, reconstruction, recovery and how to close gaps in access to care.
For Blood Cancer Awareness Month, Dr. Guenther Koehne shares why immunotherapy is making this a promising time for people with blood cancers.
A cancer survivor reflects on losing her hair during chemotherapy, the emotional impact of hair loss and what growing it back taught her about healing, identity and life.
After a lung cancer diagnosis, one Bronx writer reflects on faith, survivorship and learning that healing isn't a finish line, but a daily journey.
Dr. David DiBardino explains how intratumoral therapy is being studied to deliver treatment directly into tumors and potentially enhance radiation in patients with locally advanced non-small cell lung cancer.
Advertisement
Advertisement
Trending on CURE
1
Could a Genomic Test Spare You Extra Years of Hormone Therapy?
2
I’m Jealous of the World — and Grateful I Got to Be Part of It
3
My Sister and I Share a BRCA2 Mutation. We Didn’t Make the Same Choices
4
We Eat Bagels Before Cancer Treatment. Here’s Why.
5